Filing Details

Accession Number:
0001415889-23-000801
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-11 16:25:04
Reporting Period:
2023-01-10
Accepted Time:
2023-01-11 16:25:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1733294 Generation Bio Co. GBIO Pharmaceutical Preparations (2834) 814301281
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1907682 Antoinette Paone C/O Generation Bio Co., 301 Binney St
Cambridge MA 02142
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-10 1,865 $4.57 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. Includes 1,865 shares acquired under the company's employee stock purchase plan since October 28, 2022.